MTERF3

Chr 8

mitochondrial transcription termination factor 3

Also known as: CGI-12, MTERFD1

This protein binds mitochondrial promoter DNA and regulates transcription initiation, maintaining 16S rRNA levels and functioning in mitochondrial ribosome assembly and respiratory complex formation. Mutations cause autosomal recessive mitochondrial disorders affecting multiple organ systems. The gene shows tolerance to loss-of-function variants (LOEUF 1.276), suggesting complete loss of function may be compatible with survival in some cases.

Summary from RefSeq, UniProt
Research Assistant →
0
Active trials
5
Pubs (1 yr)
38
P/LP submissions
0%
P/LP missense
1.28
LOEUF
Multiple*
Mechanism· predicted
Clinical SummaryMTERF3
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
38 unique Pathogenic / Likely Pathogenic· 50 VUS of 100 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.28LOEUF
pLI 0.000
Z-score 0.70
OE 0.82 (0.541.28)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
-0.12Z-score
OE missense 1.02 (0.911.15)
215 obs / 210.2 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios
LoF OE0.82 (0.541.28)
00.351.4
Missense OE1.02 (0.911.15)
00.61.4
Synonymous OE0.91
01.21.6
LoF obs/exp: 14 / 17.1Missense obs/exp: 215 / 210.2Syn Z: 0.63
DN
0.6648th %ile
GOF
0.6442th %ile
LOF
0.3356th %ile

This gene has evidence for multiple mechanisms of pathogenicity (dominant-negative and gain-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to dominant-negative as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

DNprediction above median
GOFprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

100 submitted variants in ClinVar

Classification Summary

Pathogenic36
Likely Pathogenic2
VUS50
Likely Benign1
Benign1
36
Pathogenic
2
Likely Pathogenic
50
VUS
1
Likely Benign
1
Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
36
0
36
Likely Pathogenic
0
0
2
0
2
VUS
0
47
3
0
50
Likely Benign
0
1
0
0
1
Benign
0
0
1
0
1
Total04842090

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

MTERF3 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →
Recent Gene-Specific Literature
Gene in title · MEDLINE · newest first
Europe PMC